These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36717650)

  • 21. Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease.
    Kelly K; Rasko JEJ
    Front Immunol; 2021; 12():761616. PubMed ID: 34764962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
    Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
    Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
    Zhao L; Chen S; Yang P; Cao H; Li L
    Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
    Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
    Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease.
    Tang B; Li X; Liu Y; Chen X; Li X; Chu Y; Zhu H; Liu W; Xu F; Zhou F; Zhang Y
    Cell Physiol Biochem; 2018; 46(6):2624-2635. PubMed ID: 29763906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunosuppressive effects of multipotent mesenchymal stromal cells on graft-versus-host disease in rats following allogeneic bone marrow transplantation.
    Nevruz O; Avcu F; Ural AU; Pekel A; Dirican B; Safalı M; Akdağ E; Beyzadeoğlu M; Ide T; Sengül A
    Turk J Haematol; 2013 Sep; 30(3):256-62. PubMed ID: 24385804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.
    Sudres M; Norol F; Trenado A; Grégoire S; Charlotte F; Levacher B; Lataillade JJ; Bourin P; Holy X; Vernant JP; Klatzmann D; Cohen JL
    J Immunol; 2006 Jun; 176(12):7761-7. PubMed ID: 16751424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner.
    Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Cho SJ; Ryu KH
    Cytotherapy; 2010 May; 12(3):361-70. PubMed ID: 20078382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioimaging for the monitoring of the in vivo distribution of infused mesenchymal stem cells in a mouse model of the graft-versus-host reaction.
    Joo SY; Cho KA; Jung YJ; Kim HS; Park SY; Choi YB; Hong KM; Woo SY; Seoh JY; Ryu KH
    Cell Biol Int; 2011 Apr; 35(4):417-21. PubMed ID: 21062262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
    Introna M; Golay J
    Front Immunol; 2020; 11():609063. PubMed ID: 33362797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of bone marrow-derived mesenchymal stem cells in reduction of graft-versus-host disease by effecting CD4+CD25+ regulatory T cells in rats].
    Tian Y; Deng YB; Huang YJ; Na XD; Li Y; Ye MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1210-4. PubMed ID: 17204196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal Stromal Cells Stimulate the Proliferation and IL-22 Production of Group 3 Innate Lymphoid Cells.
    van Hoeven V; Munneke JM; Cornelissen AS; Omar SZ; Spruit MJ; Kleijer M; Bernink JH; Blom B; Voermans C; Hazenberg MD
    J Immunol; 2018 Aug; 201(4):1165-1173. PubMed ID: 29980610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
    Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
    J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.
    Polchert D; Sobinsky J; Douglas G; Kidd M; Moadsiri A; Reina E; Genrich K; Mehrotra S; Setty S; Smith B; Bartholomew A
    Eur J Immunol; 2008 Jun; 38(6):1745-55. PubMed ID: 18493986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus-Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration in a Mouse Model.
    Lim JY; Ryu DB; Lee SE; Park G; Min CK
    J Invest Dermatol; 2017 Sep; 137(9):1895-1904. PubMed ID: 28526296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.
    Mielcarek M; Storb R; Georges GE; Golubev L; Nikitine A; Hwang B; Nash RA; Torok-Storb B
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):214-25. PubMed ID: 20816818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.